Latest App Notes & Case Studies

By collecting more light and better correcting for light distortion, water immersion capabilities can unlock advanced imaging potential for greater insight into cellular pathways and processes.

Biotherapeutics must go through rigorous purification processes during their development and manufacturing. However, low levels of residual or plasmid DNA can often remain after purification, affecting the safety and efficacy of final products.

This application note presents the latest electrophoretic solutions for a more rapid assessment of cfDNA samples and optimal biomarker discovery.

These materials highlight the use of single cell dispensers that enhance efficiency and predictability, improving workflow robustness to support safe and cost-effective biopharmaceutical manufacturing.

This app note highlights a method for generating highly standardized, assay- ready PDOs and demonstrates their utility in high-throughput applications.

This app note highlights the latest ddPCRTM solutions for advanced assay multiplexing. It demonstrates how researchers can get the most out of precious clinical samples, with time and cost-saving advantages over gene sequencing methods.

To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.

Targeted sequencing based on NGS offers new perspectives in drug selection for cancer patients. The accuracy of mutation analysis relies on the tumor content of the tissue samples.

The composition of the cryopreservation medium can have a big impact on the recovery of viable cells after thawing. Learn how long-term cryopreservation with MACS® Freezing Solution can maintain the viability and stability of cell suspensions and tissue samples.

This application note demonstrates how reliable kinetics and affinity can be obtained from single measurement data, increasing sample throughput and saving sample material.